DexCom Work in process increased by 29.5% to $136.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 111.5%, from $64.30M to $136.00M. Over 4 years (FY 2020 to FY 2025), Work in process shows an upward trend with a 64.9% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase may indicate production bottlenecks or scaling efforts, while a decrease suggests efficient throughput or reduced manufacturing activity.
Represents the value of goods that have entered the production process but are not yet finished. For a manufacturer like...
Peers in medical device manufacturing typically maintain lean WIP levels to optimize cash conversion cycles.
inv_work_in_progress| Q2 '21 | Q3 '21 | Q4 '22 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $13.60M | $18.40M | $17.20M | $36.40M | $27.50M | $30.00M | $49.80M | $64.80M | $49.80M | $28.10M | $64.30M | $94.00M | $78.60M | $105.00M | $136.00M |
| QoQ Change | — | +35.3% | -6.5% | +111.6% | -24.5% | +9.1% | +66.0% | +30.1% | -23.1% | -43.6% | +128.8% | +46.2% | -16.4% | +33.6% | +29.5% |
| YoY Change | — | — | — | — | — | +74.4% | — | +78.0% | +81.1% | -6.3% | +29.1% | +45.1% | +57.8% | +273.7% | +111.5% |
| % of Inventories | 4.3% | 5.2% | 5.6% | 8.6% | 5.5% | 5.4% | 8.5% | 11.4% | 8.5% | 5.2% | 11.9% | 16.5% | 13.0% | 16.7% | 19.6% |
| Share Change | — | +1.0pp | +0.4pp | +3.0pp | -3.1pp | -0.2pp | +3.1pp | +2.9pp | -2.9pp | -3.3pp | +6.8pp | +4.5pp | -3.5pp | +3.7pp | +2.9pp |